B&A Therapeutics Overview

  • Founded
  • 2014

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

B&A Therapeutics General Information


Developer of novel therapies intended to treat neurological diseases. The company develops medicines for neurological and neurodegenerative diseases such as Parkinson's and Huntington's, enabling healthcare providers to have access to new medicines to treat patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Batiment Beret-Delaage, Zone Luminy Biotech
  • Case 922, 163 Avenue de Luminy, cedex 09
  • 13288 Marsheille
  • France
+33 04 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

B&A Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view B&A Therapeutics’s complete valuation and funding history, request access »

B&A Therapeutics Executive Team (9)

Name Title Board Seat Contact Info
Yehezkel Ben-Ari Ph.D Co-Founder, President & Chief Executive Officer
Constance Hammond Co-Founder & Managing Director
Philippe Damier Ph.D Principal Investigator
Romain Nardou Executive
Denis Ravel Co-Founder
You’re viewing 5 of 9 executive team members. Get the full list »

B&A Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Incubateur Impulse Accelerator/Incubator 000 0000 000000 0
To view B&A Therapeutics’s complete investors history, request access »